Straumann Holding AG (LON: 0QMV)
London
· Delayed Price · Currency is GBP · Price in CHF
124.70
-1.01 (-0.80%)
Jul 22, 2022, 8:30 AM BST
Straumann Holding AG Revenue
Straumann Holding AG had revenue of 1.27B CHF in the half year ending June 30, 2024, with 8.05% growth. This brings the company's revenue in the last twelve months to 2.54B, up 11.15% year-over-year. In the year 2023, Straumann Holding AG had annual revenue of 2.41B with 3.92% growth.
Revenue (ttm)
2.54B CHF
Revenue Growth
+11.15%
P/S Ratio
n/a
Revenue / Employee
228.75K CHF
Employees
11,109
Market Cap
18.47B GBP
Revenue Chart
* This company reports financials in CHF.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 2.41B | 91.03M | 3.92% |
Dec 31, 2022 | 2.32B | 298.88M | 14.78% |
Dec 31, 2021 | 2.02B | 596.05M | 41.80% |
Dec 31, 2020 | 1.43B | -170.37M | -10.67% |
Dec 31, 2019 | 1.60B | 232.67M | 17.06% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 38.20B |
GSK plc | 31.31B |
Haleon | 11.24B |
Smith & Nephew | 4.46B |
ConvaTec Group | 1.74B |
Hikma Pharmaceuticals | 2.39B |
HUTCHMED (China) | 483.31M |
Oxford Nanopore Technologies | 167.75M |